Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia

Neurology

Volumn 50, Issue 4, 1998, Pages 1015-1020

  Furukawa, Y ^a   Lang, A E ^b   Trugman, J M ^d   Bird, T D ^e   Hunter, A ^c   Sadeh, M ^f   Tagawa, T ^g   St George Hyslop, P H ⁱ   Guttman, M ^a   Morris, L W ^a   Hornykiewicz, O ⁱ   Shimadzu, M ^h   Kish, S J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WOLFSON MEDICAL CENTER   (Israel)

^g OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^h LSI MEDIENCE CORPORATION   (Japan)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; DNA SEQUENCE; DYSTONIA; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENOME IMPRINTING; HUMAN; MALE; PEDIGREE; PENETRANCE; PRIORITY JOURNAL;

EID: 0031943362     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.1015     Document Type: Article

References (36)

1. Segawa M, Nomura Y. Hereditary progressive dystonia with marked diurnal fluctuation. In: Segawa M, ed. Hereditary progressive dystonia with marked diurnal fluctuation. Lancs, UK: Parthenon Publishing, 1993:3-19.
2. Nygaard TG, Snow BJ, Fahn S, Calne DB. Dopa-responsive dystonia: clinical characteristics and definition. In: Segawa M, ed. Hereditary progressive dystonia with marked diurnal fluctuation. Lanes, UK: Parthenon Publishing, 1993:21-35.
3. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet 1994; 8:236-242.
4. Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa-responsive dystonia. Biochem Biophys Res Commun 1995;213:645-651.
5. Ichinose H, Ohye T, Segawa M, et al. GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett 1995;196:5-8.
6. Furukawa Y, Shimadzu M. Rajput AH, et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 1996;39:609-617.
7. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996;5: 403-406.
8. Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S. Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset. Ann Neurol 1996; 40:796-798.
9. Beyer K, Lao-Villadóniga JI, Vecino-Bilbao B, Cacabelos R, de la Fuente-Fernández R. A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia. J Neurol Neurosurg Psychiatry 1997;62:420-421.
10. Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988;38:707-711.
11. Furukawa Y, Nishi K, Kondo T, Mizuno Y, Narabayashi H. CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Adv Neurol 1993;60:562-567.
12. Takahashi H, Levine RA, Galloway MP, Snow BJ, Calne DB, Nygaard TG. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 1994;35:354-356.
13. Furukawa Y, Mizuno Y, Narabayshi H. Early-onset parkinsonism with dystonia: clinical and biochemical differences from hereditary progressive dystonia or dopa-responsive dystonia. Adv Neurol 1996;69:327-337.
14. Rajput AH, Gibb WRG, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994;35:396-402.
15. Furukawa Y, Rajput A, Nygaard T, Hornykiewicz O, Kish S. Biopterin biosynthetic abnormality in brains of patients with hereditary progressive and dopa-responsive dystonia. Mov Disord 1997;12:A37. Abstract.
16. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69.
17. Hall JG. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 1990;46:857-873.
18. Eapen V, O'Neill J, Gurling HMD, Robertson MM. Sex of parent transmission effect in Tourette's syndrome: evidence of earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 1997;48:934-937.
19. Lichter DG, Jackson LA, Schachter M. Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 1995; 45:924-928.
20. Hyland K, Fryburg JS, Wilson WG, et al. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 1997;48:1290-1297.
21. Furukawa Y, Kish SJ, Bebin EM, et al. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol 1998 (in press).
22. Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res 1982;10:459-472.
23. Togari A, Ichinose H, Matsumoto S, Fujita K, Nagatsu T. Multiple mRNA forms of human GTP cyclohydrolase I. Biochem Biophys Res Commun 1992;187:359-365.
24. Imazumi K, Sasaki T, Takahashi K, Takai Y. Identification of a Rabphilin-3A-interacting protein as GTP cyclohydrolase I in PC12 cells. Biochem Biophy Res Commun 1994;205:1409-1416.
25. Nomura T, Ichinose H, Sumi-Ichinose C, et al. Cloning and sequencing of cDNA encoding mouse GTP cyclohydrolase I. Biochem Biophy Res Commun 1993;191:523-527.
26. Jeon BS, Chung J-M, Lee M-C. Dopamine transporter imaging is useful to diagnose dopa-responsive dystonia. Neurology 1997;48(suppl 2):A61-A62. Abstract.
27. Nygaard TG, Wilhelmsen KC, Risch NJ, et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nature Genet 1993;5:386-391.
28. Reisert I, Pilgrim C. Sexual differentiation of monoaminergic neurons-genetic or epigenetic? Trends Neurosci 1991;14:468-473.
29. Bédard PJ, Langelier P, Dankova J, et al. Estrogens, progesterone, and the extrapyramidal system. Adv Neurol 1979;24: 411-422.
30. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27:81-141.
31. Beaudet AL, Scriver CR, Sly WS, Valle D. Genetics, biochemistry, and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995:53-118.
32. Neel JV, Mohrenweiser HW, Meisler MH. Rate of spontaneous mutation at human loci encoding protein structure. Proc Natl Acad Sci USA 1980;77:6037-6041.
33. Bressman SB, de Leon D, Kramer PL, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994;36:771-777.
34. Ozelius LJ, Hewett J, Kramer P, et al. Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Res 1997;7: 483-494.
35. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R, Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996;5:1673-1677.
36. Leube B, Hendgen T, Kessler KR, Knapp M, Benecke R, Auburger G. Sporadic focal dystonia in Northwest Germany: molecular basis on chromosome 18p. Ann Neurol 1997;42:111-114.